Captrust Financial Advisors Seres Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $1,417 - $1,989	-225 Reduced 69.02%	101 $1,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $608 - $1,154	101 Added 44.89%	326 $3,000
Q3 2021 Nov 16, 2021	SELL	$5.46 - $22.6 $1,588 - $6,576	-291 Reduced 56.4%	225 $2,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $6,405 - $8,452	347 Added 205.33%	516 $12,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $2,984 - $4,887	169 New	169 $3,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.